ID   GAL4_YEAST              Reviewed;         881 AA.
AC   P04386; D6W3C3;
DT   20-MAR-1987, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   07-APR-2021, entry version 201.
DE   RecName: Full=Regulatory protein GAL4;
GN   Name=GAL4; OrderedLocusNames=YPL248C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6366516; DOI=10.1128/mcb.4.2.260;
RA   Laughon A., Gesteland R.F.;
RT   "Primary structure of the Saccharomyces cerevisiae GAL4 gene.";
RL   Mol. Cell. Biol. 4:260-267(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169875;
RA   Bussey H., Storms R.K., Ahmed A., Albermann K., Allen E., Ansorge W.,
RA   Araujo R., Aparicio A., Barrell B.G., Badcock K., Benes V., Botstein D.,
RA   Bowman S., Brueckner M., Carpenter J., Cherry J.M., Chung E.,
RA   Churcher C.M., Coster F., Davis K., Davis R.W., Dietrich F.S., Delius H.,
RA   DiPaolo T., Dubois E., Duesterhoeft A., Duncan M., Floeth M., Fortin N.,
RA   Friesen J.D., Fritz C., Goffeau A., Hall J., Hebling U., Heumann K.,
RA   Hilbert H., Hillier L.W., Hunicke-Smith S., Hyman R.W., Johnston M.,
RA   Kalman S., Kleine K., Komp C., Kurdi O., Lashkari D., Lew H., Lin A.,
RA   Lin D., Louis E.J., Marathe R., Messenguy F., Mewes H.-W., Mirtipati S.,
RA   Moestl D., Mueller-Auer S., Namath A., Nentwich U., Oefner P., Pearson D.,
RA   Petel F.X., Pohl T.M., Purnelle B., Rajandream M.A., Rechmann S.,
RA   Rieger M., Riles L., Roberts D., Schaefer M., Scharfe M., Scherens B.,
RA   Schramm S., Schroeder M., Sdicu A.-M., Tettelin H., Urrestarazu L.A.,
RA   Ushinsky S., Vierendeels F., Vissers S., Voss H., Walsh S.V., Wambutt R.,
RA   Wang Y., Wedler E., Wedler H., Winnett E., Zhong W.-W., Zollner A.,
RA   Vo D.H., Hani J.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI.";
RL   Nature 387:103-105(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   MUTAGENESIS, AND ZINC REQUIREMENT.
RX   PubMed=3299106; DOI=10.1038/328353a0;
RA   Johnston M.;
RT   "Genetic evidence that zinc is an essential co-factor in the DNA binding
RT   domain of GAL4 protein.";
RL   Nature 328:353-355(1987).
RN   [5]
RP   INTERACTION WITH SRB4.
RX   PubMed=9660972; DOI=10.1016/s1097-2765(00)80088-x;
RA   Koh S.S., Ansari A.Z., Ptashne M., Young R.A.;
RT   "An activator target in the RNA polymerase II holoenzyme.";
RL   Mol. Cell 1:895-904(1998).
RN   [6]
RP   INTERACTION WITH GAL11.
RX   PubMed=11478912; DOI=10.1021/bi010011k;
RA   Jeong C.-J., Yang S.-H., Xie Y., Zhang L., Johnston S.A., Kodadek T.;
RT   "Evidence that Gal11 protein is a target of the Gal4 activation domain in
RT   the mediator.";
RL   Biochemistry 40:9421-9427(2001).
RN   [7]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [8]
RP   DOMAIN.
RX   PubMed=17467953; DOI=10.1016/j.ygeno.2007.02.003;
RA   Piskacek S., Gregor M., Nemethova M., Grabner M., Kovarik P., Piskacek M.;
RT   "Nine-amino-acid transactivation domain: establishment and prediction
RT   utilities.";
RL   Genomics 89:756-768(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-712, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-694; SER-696; SER-699 AND
RP   SER-703, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides insights
RT   into evolution.";
RL   Science 325:1682-1686(2009).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1-65.
RX   PubMed=1557122; DOI=10.1038/356408a0;
RA   Marmorstein R., Carey M., Ptashne M., Harrison S.C.;
RT   "DNA recognition by GAL4: structure of a protein-DNA complex.";
RL   Nature 356:408-414(1992).
RN   [12]
RP   STRUCTURE BY NMR OF ZINC-BINDING REGION.
RX   PubMed=2107541; DOI=10.1073/pnas.87.6.2077;
RA   Pan T., Coleman J.E.;
RT   "GAL4 transcription factor is not a 'zinc finger' but forms a Zn(II)2Cys6
RT   binuclear cluster.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2077-2081(1990).
RN   [13]
RP   STRUCTURE BY NMR OF ZINC-BINDING REGION.
RX   PubMed=2021614; DOI=10.1021/bi00231a016;
RA   Pan T., Coleman J.E.;
RT   "Sequential assignments of the 1H NMR resonances of Zn(II)2 and 113Cd(II)2
RT   derivatives of the DNA-binding domain of the GAL4 transcription factor
RT   reveal a novel structural motif for specific DNA recognition.";
RL   Biochemistry 30:4212-4222(1991).
RN   [14]
RP   STRUCTURE BY NMR OF ZINC-BINDING REGION.
RX   PubMed=2265711; DOI=10.1016/0014-5793(90)80504-c;
RA   Gadhavi P.L., Raine A.R.C., Alefounder P.R., Laue E.D.;
RT   "Complete assignment of the 1H NMR spectrum and secondary structure of the
RT   DNA binding domain of GAL4.";
RL   FEBS Lett. 276:49-53(1990).
RN   [15]
RP   STRUCTURE BY NMR OF ZINC-BINDING REGION.
RX   PubMed=1557129; DOI=10.1038/356448a0;
RA   Kraulis P.J., Raine A.R.C., Gadhavi P.L., Laue E.D.;
RT   "Structure of the DNA-binding domain of zinc GAL4.";
RL   Nature 356:448-450(1992).
RN   [16]
RP   STRUCTURE BY NMR OF ZINC-BINDING REGION.
RX   PubMed=1557130; DOI=10.1038/356450a0;
RA   Baleja J.D., Marmorstein R., Harrison S.C., Wagner G.;
RT   "Solution structure of the DNA-binding domain of Cd2-GAL4 from S.
RT   cerevisiae.";
RL   Nature 356:450-453(1992).
CC   -!- FUNCTION: This protein is a positive regulator for the gene expression
CC       of the galactose-induced genes such as GAL1, GAL2, GAL7, GAL10, and
CC       MEL1 which code for the enzymes used to convert galactose to glucose.
CC       It recognizes a 17 base pair sequence in (5'-CGGRNNRCYNYNCNCCG-3') the
CC       upstream activating sequence (UAS-G) of these genes.
CC   -!- SUBUNIT: Binds DNA as a homodimer. Interacts directly with the mediator
CC       subunits GAL11/MED15 and SRB4/MED17. {ECO:0000269|PubMed:11478912,
CC       ECO:0000269|PubMed:9660972}.
CC   -!- INTERACTION:
CC       P04386; P04386: GAL4; NbExp=3; IntAct=EBI-4407660, EBI-4407660;
CC       P04386; P04387: GAL80; NbExp=3; IntAct=EBI-4407660, EBI-2061197;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DOMAIN: the 9aaTAD motif (residues 862 to 870) is a transactivation
CC       domain present in a large number of yeast and animal transcription
CC       factors. {ECO:0000269|PubMed:17467953}.
CC   -!- PTM: Association between GAL11 and GAL4 may serve to expedite
CC       phosphorylation of GAL4.
CC   -!- MISCELLANEOUS: Present with 166 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; K01486; AAA34626.1; -; Genomic_DNA.
DR   EMBL; Z67751; CAA91596.1; -; Genomic_DNA.
DR   EMBL; Z73604; CAA97969.1; -; Genomic_DNA.
DR   EMBL; BK006949; DAA11189.1; -; Genomic_DNA.
DR   PIR; A05022; RGBYG4.
DR   RefSeq; NP_015076.1; NM_001184062.1.
DR   PDB; 1AW6; NMR; -; A=1-43.
DR   PDB; 1D66; X-ray; 2.70 A; A/B=1-65.
DR   PDB; 1HBW; NMR; -; A/B=50-106.
DR   PDB; 3BTS; X-ray; 2.70 A; E/F=854-874.
DR   PDB; 3COQ; X-ray; 2.40 A; A/B=8-96.
DR   PDBsum; 1AW6; -.
DR   PDBsum; 1D66; -.
DR   PDBsum; 1HBW; -.
DR   PDBsum; 3BTS; -.
DR   PDBsum; 3COQ; -.
DR   BMRB; P04386; -.
DR   SMR; P04386; -.
DR   BioGRID; 35915; 176.
DR   ComplexPortal; CPX-1044; GAL4-GAL80 transcription repressor complex.
DR   DIP; DIP-593N; -.
DR   IntAct; P04386; 6.
DR   MINT; P04386; -.
DR   STRING; 4932.YPL248C; -.
DR   iPTMnet; P04386; -.
DR   PaxDb; P04386; -.
DR   PRIDE; P04386; -.
DR   EnsemblFungi; YPL248C_mRNA; YPL248C; YPL248C.
DR   GeneID; 855828; -.
DR   KEGG; sce:YPL248C; -.
DR   SGD; S000006169; GAL4.
DR   VEuPathDB; FungiDB:YPL248C; -.
DR   eggNOG; ENOG502QSMN; Eukaryota.
DR   HOGENOM; CLU_008599_2_0_1; -.
DR   InParanoid; P04386; -.
DR   OMA; MFNTTTM; -.
DR   EvolutionaryTrace; P04386; -.
DR   PRO; PR:P04386; -.
DR   Proteomes; UP000002311; Chromosome XVI.
DR   RNAct; P04386; protein.
DR   GO; GO:0005634; C:nucleus; IDA:SGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:SGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IMP:SGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:SGD.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IDA:SGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006012; P:galactose metabolic process; IMP:SGD.
DR   GO; GO:0000435; P:positive regulation of transcription from RNA polymerase II promoter by galactose; IDA:SGD.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00067; GAL4; 1.
DR   CDD; cd14654; ZIP_Gal4; 1.
DR   DisProt; DP02132; -.
DR   Gene3D; 4.10.240.10; -; 1.
DR   InterPro; IPR005600; Gal4_dimer_dom.
DR   InterPro; IPR007219; Transcription_factor_dom_fun.
DR   InterPro; IPR001138; Zn2-C6_fun-type_DNA-bd.
DR   InterPro; IPR036864; Zn2-C6_fun-type_DNA-bd_sf.
DR   Pfam; PF04082; Fungal_trans; 1.
DR   Pfam; PF03902; Gal4_dimer; 1.
DR   Pfam; PF00172; Zn_clus; 1.
DR   SMART; SM00906; Fungal_trans; 1.
DR   SMART; SM00066; GAL4; 1.
DR   SUPFAM; SSF57701; SSF57701; 1.
DR   PROSITE; PS00463; ZN2_CY6_FUNGAL_1; 1.
DR   PROSITE; PS50048; ZN2_CY6_FUNGAL_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Carbohydrate metabolism; DNA-binding;
KW   Galactose metabolism; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation; Zinc.
FT   CHAIN           1..881
FT                   /note="Regulatory protein GAL4"
FT                   /id="PRO_0000114951"
FT   DNA_BIND        11..38
FT                   /note="Zn(2)-C6 fungal-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00227"
FT   MOTIF           862..870
FT                   /note="9aaTAD"
FT   METAL           11
FT                   /note="Zinc 1"
FT   METAL           11
FT                   /note="Zinc 2"
FT   METAL           14
FT                   /note="Zinc 1"
FT   METAL           21
FT                   /note="Zinc 1"
FT   METAL           28
FT                   /note="Zinc 1"
FT   METAL           28
FT                   /note="Zinc 2"
FT   METAL           31
FT                   /note="Zinc 2"
FT   METAL           38
FT                   /note="Zinc 2"
FT   MOD_RES         694
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         696
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         699
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         703
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         712
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956"
FT   MUTAGEN         26
FT                   /note="P->L: Loss of DNA-binding."
FT                   /evidence="ECO:0000269|PubMed:3299106"
FT   HELIX           12..17
FT                   /evidence="ECO:0007744|PDB:3COQ"
FT   STRAND          25..27
FT                   /evidence="ECO:0007744|PDB:3COQ"
FT   HELIX           29..33
FT                   /evidence="ECO:0007744|PDB:3COQ"
FT   HELIX           51..71
FT                   /evidence="ECO:0007744|PDB:3COQ"
FT   STRAND          73..75
FT                   /evidence="ECO:0007744|PDB:3COQ"
FT   HELIX           77..82
FT                   /evidence="ECO:0007744|PDB:3COQ"
FT   HELIX           86..93
FT                   /evidence="ECO:0007744|PDB:3COQ"
SQ   SEQUENCE   881 AA;  99403 MW;  29D7FF68B0B05880 CRC64;
     MKLLSSIEQA CDICRLKKLK CSKEKPKCAK CLKNNWECRY SPKTKRSPLT RAHLTEVESR
     LERLEQLFLL IFPREDLDMI LKMDSLQDIK ALLTGLFVQD NVNKDAVTDR LASVETDMPL
     TLRQHRISAT SSSEESSNKG QRQLTVSIDS AAHHDNSTIP LDFMPRDALH GFDWSEEDDM
     SDGLPFLKTD PNNNGFFGDG SLLCILRSIG FKPENYTNSN VNRLPTMITD RYTLASRSTT
     SRLLQSYLNN FHPYCPIVHS PTLMMLYNNQ IEIASKDQWQ ILFNCILAIG AWCIEGESTD
     IDVFYYQNAK SHLTSKVFES GSIILVTALH LLSRYTQWRQ KTNTSYNFHS FSIRMAISLG
     LNRDLPSSFS DSSILEQRRR IWWSVYSWEI QLSLLYGRSI QLSQNTISFP SSVDDVQRTT
     TGPTIYHGII ETARLLQVFT KIYELDKTVT AEKSPICAKK CLMICNEIEE VSRQAPKFLQ
     MDISTTALTN LLKEHPWLSF TRFELKWKQL SLIIYVLRDF FTNFTQKKSQ LEQDQNDHQS
     YEVKRCSIML SDAAQRTVMS VSSYMDNHNV TPYFAWNCSY YLFNAVLVPI KTLLSNSKSN
     AENNETAQLL QQINTVLMLL KKLATFKIQT CEKYIQVLEE VCAPFLLSQC AIPLPHISYN
     NSNGSAIKNI VGSATIAQYP TLPEENVNNI SVKYVSPGSV GPSPVPLKSG ASFSDLVKLL
     SNRPPSRNSP VTIPRSTPSH RSVTPFLGQQ QQLQSLVPLT PSALFGGANF NQSGNIADSS
     LSFTFTNSSN GPNLITTQTN SQALSQPIAS SNVHDNFMNN EITASKIDDG NNSKPLSPGW
     TDQTAYNAFG ITTGMFNTTT MDDVYNYLFD DEDTPPNPKK E
//
